Drug maker Lupin said on Thursday that it has resumed US sales of its copy of Shionogi Inc's Fortamet tablets, a type 2 diabetes treatment drug.
A US district court in New Jersey has granted motion for a preliminary injunction against Lupin's generic version of anti-diabetes drug Fortamet.
Lupin had launched Fortamet, a diabetic drug, at risk in the US, causing an injunction against the drug. Chief Financial Officer S Ramesh clarified that Fortamet generic was launched only for few days.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.